Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Value Investing -- Ignore unavailable to you. Want to Upgrade?

To: Paul Senior who wrote (41792)	3/16/2011 1:04:50 PM
From: Wallace Rivers	Read Replies (1) \| Respond to of 78596

I need some funds to settle, at which point I will add to a small JNJ position to make it a full position. Also, own EXC, and have a lower bid in now for more.

To: Paul Senior who wrote (41792)	3/16/2011 1:21:21 PM
From: E_K_S	Read Replies (1) \| Respond to of 78596

Hi Paul - Re: Johnson & Johnson (JNJ) My Drug Company watch list was looking interesting today. Specifically MRK under $30.00/share may present a good buying opportunity. I added JNJ to the list based on your post. I pretty much stopped watching it since they have had so many quality production issues. My last transaction was 12/2009 where I closed out my position at $64.00/share. Buffet still maintains his holdings in the company w/ the 4th largest individual position. Johnson & Johnson (JNJ) Stock Holdings Summary (Ownership) As of 12/31/2010 nasdaq.com STATE STREET CORP 12/31/2010 138,223,181 2,619,253 1.93% $8,083,292 VANGUARD GROUP INC 12/31/2010 103,063,329 (409,900) (0.40%) $6,027,143 BARCLAYS GLOBAL INVE... 12/31/2010 70,860,571 1,126,303 1.62% $4,143,926 BERKSHIRE HATHAWAY I... 12/31/2010 42,624,563 0 0.00% $2,492,684 BANK OF NEW YORK MEL... 12/31/2010 40,847,705 248,680 0.61% $2,388,774 FWIW, "Value Cruncher" ( valuecruncher.com ) has a value of $86.84/share for Johnson & Johnson (JNJ). Is the stock really 48% undervalued? ( I doubt it). EKS

To: Paul Senior who wrote (41792)	3/18/2011 3:00:04 PM
From: Wallace Rivers	Read Replies (1) \| Respond to of 78596

Purchased more JNJ today at 58.19

To: Paul Senior who wrote (41792)	3/20/2011 6:33:06 PM
From: Jurgis Bekepuris	Read Replies (1) \| Respond to of 78596

It's that time of the year... filling proxy statements. Executive compensations continues to be egregious in most of the companies. It's amazing how JNJ BOD finds great reasons to pay CEO $29M while the company continues to fumble through quality issues and recalls destroying its brand cachet. What would it take for them to reduce the bonuses? CEO announcing that the company would reduce drug prices for the poor? Yeah, probably that's the ticket. Anyway I voted against executive compensation so far for every company not counting BRK and FRFHF. Hmm, I'm not sure FRFHF asked to vote on executive compensation, but I would have voted for it. Fairfax chairman's letter is worth reading ( fairfax.ca ) even if he channels Buffett a bit. So vote early and vote often.